• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不断发展的认识:DNA 修复途径如何影响癌症演进。

Evolving insights: how DNA repair pathways impact cancer evolution.

机构信息

Department of Radiation Medicine, Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.

Laboratory of Cancer Cell Biology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.

出版信息

Cancer Biol Med. 2020 Nov 15;17(4):805-827. doi: 10.20892/j.issn.2095-3941.2020.0177. Epub 2020 Dec 15.

DOI:10.20892/j.issn.2095-3941.2020.0177
PMID:33299637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7721097/
Abstract

Viewing cancer as a large, evolving population of heterogeneous cells is a common perspective. Because genomic instability is one of the fundamental features of cancer, this intrinsic tendency of genomic variation leads to striking intratumor heterogeneity and functions during the process of cancer formation, development, metastasis, and relapse. With the increased mutation rate and abundant diversity of the gene pool, this heterogeneity leads to cancer evolution, which is the major obstacle in the clinical treatment of cancer. Cells rely on the integrity of DNA repair machineries to maintain genomic stability, but these machineries often do not function properly in cancer cells. The deficiency of DNA repair could contribute to the generation of cancer genomic instability, and ultimately promote cancer evolution. With the rapid advance of new technologies, such as single-cell sequencing in recent years, we have the opportunity to better understand the specific processes and mechanisms of cancer evolution, and its relationship with DNA repair. Here, we review recent findings on how DNA repair affects cancer evolution, and discuss how these mechanisms provide the basis for critical clinical challenges and therapeutic applications.

摘要

将癌症视为一个由异质细胞组成的大型、不断进化的群体是一种常见的观点。由于基因组不稳定性是癌症的基本特征之一,这种基因组变异的内在趋势导致了肿瘤内的显著异质性,并在癌症形成、发展、转移和复发的过程中发挥作用。随着基因突变率的增加和基因库的丰富多样性,这种异质性导致了癌症的进化,这是癌症临床治疗的主要障碍。细胞依赖于 DNA 修复机制的完整性来维持基因组的稳定性,但这些机制在癌细胞中往往不能正常工作。DNA 修复的缺陷可能导致癌症基因组不稳定性的产生,并最终促进癌症的进化。随着新技术的快速发展,例如近年来的单细胞测序技术,我们有机会更好地了解癌症进化的具体过程和机制,以及它与 DNA 修复的关系。在这里,我们回顾了 DNA 修复如何影响癌症进化的最新发现,并讨论了这些机制如何为关键的临床挑战和治疗应用提供基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844c/7721097/e0f835d66109/cbm-17-805-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844c/7721097/a44c6087c6be/cbm-17-805-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844c/7721097/e0f835d66109/cbm-17-805-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844c/7721097/a44c6087c6be/cbm-17-805-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/844c/7721097/e0f835d66109/cbm-17-805-g002.jpg

相似文献

1
Evolving insights: how DNA repair pathways impact cancer evolution.不断发展的认识:DNA 修复途径如何影响癌症演进。
Cancer Biol Med. 2020 Nov 15;17(4):805-827. doi: 10.20892/j.issn.2095-3941.2020.0177. Epub 2020 Dec 15.
2
Multiple mechanisms account for genomic instability and molecular mutation in neoplastic transformation.多种机制导致肿瘤转化过程中的基因组不稳定和分子突变。
Clin Chem. 1995 May;41(5):644-57.
3
The accumulation of DNA repair defects is the molecular origin of carcinogenesis.DNA修复缺陷的积累是致癌作用的分子起源。
Tumour Biol. 2013 Dec;34(6):3293-302. doi: 10.1007/s13277-013-1038-y. Epub 2013 Aug 2.
4
Impact of hypoxia on DNA repair and genome integrity.缺氧对 DNA 修复和基因组完整性的影响。
Mutagenesis. 2020 Feb 13;35(1):61-68. doi: 10.1093/mutage/gez019.
5
Oxidatively induced DNA damage: mechanisms, repair and disease.氧化诱导的 DNA 损伤:机制、修复与疾病。
Cancer Lett. 2012 Dec 31;327(1-2):26-47. doi: 10.1016/j.canlet.2012.01.016. Epub 2012 Jan 28.
6
Endogenous DNA Damage as a Source of Genomic Instability in Cancer.内源性DNA损伤作为癌症基因组不稳定的一个来源。
Cell. 2017 Feb 9;168(4):644-656. doi: 10.1016/j.cell.2017.01.002.
7
The causes and consequences of genetic heterogeneity in cancer evolution.癌症进化中遗传异质性的原因和后果。
Nature. 2013 Sep 19;501(7467):338-45. doi: 10.1038/nature12625.
8
Perturbations in the Replication Program Contribute to Genomic Instability in Cancer.复制程序中的扰动导致癌症中的基因组不稳定。
Int J Mol Sci. 2017 May 25;18(6):1138. doi: 10.3390/ijms18061138.
9
DNA repair gene--XRCC1 in relation to genome instability and role in colorectal carcinogenesis.DNA 修复基因 XRCC1 与基因组不稳定性及结直肠癌发生中的作用。
Oncol Res Treat. 2014;37(7-8):418-22. doi: 10.1159/000364898. Epub 2014 Jun 17.
10
DNA Repair--A Double-Edged Sword in the Genomic Stability of Cancer Cells--The Case of Chronic Myeloid Leukemia.DNA修复——癌细胞基因组稳定性中的双刃剑——以慢性粒细胞白血病为例
Int J Mol Sci. 2015 Nov 18;16(11):27535-49. doi: 10.3390/ijms161126049.

引用本文的文献

1
Microsatellite instability and PD-L1 expression in sarcomas: current evidence and clinical perspectives.肉瘤中的微卫星不稳定性和PD-L1表达:当前证据与临床前景
Med Oncol. 2025 Sep 17;42(11):477. doi: 10.1007/s12032-025-03039-y.
2
Two Decades of Disease Evolution and Biomarker-Guided Clinical Decision Making in Metastatic Prostate Cancer.转移性前列腺癌二十年的疾病演变及生物标志物指导下的临床决策制定
Int J Mol Sci. 2025 Aug 6;26(15):7593. doi: 10.3390/ijms26157593.
3
Influence of Hypoxia on Tumor Heterogeneity, DNA Repair, and Cancer Therapy: From Molecular Insights to Therapeutic Strategies.

本文引用的文献

1
MTOR signaling orchestrates stress-induced mutagenesis, facilitating adaptive evolution in cancer.mTOR 信号调控应激诱导的突变,促进癌症中的适应性进化。
Science. 2020 Jun 5;368(6495):1127-1131. doi: 10.1126/science.aau8768.
2
Interplay between DNA damage repair and apoptosis shapes cancer evolution through aneuploidy and microsatellite instability.DNA 损伤修复与细胞凋亡的相互作用通过非整倍体和微卫星不稳定性塑造癌症进化。
Nat Commun. 2020 Mar 6;11(1):1234. doi: 10.1038/s41467-020-15094-2.
3
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
缺氧对肿瘤异质性、DNA修复及癌症治疗的影响:从分子洞察到治疗策略
Cells. 2025 Jul 10;14(14):1057. doi: 10.3390/cells14141057.
4
Resolving tumor evolution: a phylogenetic approach.解析肿瘤进化:一种系统发育学方法。
J Natl Cancer Cent. 2024 Mar 21;4(2):97-106. doi: 10.1016/j.jncc.2024.03.001. eCollection 2024 Jun.
5
Polyploid giant cancer cells induced by Docetaxel exhibit a senescence phenotype with the expression of stem cell markers in ovarian cancer cells.多倍体巨癌细胞由多西紫杉醇诱导,在卵巢癌细胞中表现出衰老表型和干细胞标志物的表达。
PLoS One. 2024 Jul 11;19(7):e0306969. doi: 10.1371/journal.pone.0306969. eCollection 2024.
6
The Role of Insulin-like Growth Factor Binding Protein (IGFBP)-2 in DNA Repair and Chemoresistance in Breast Cancer Cells.胰岛素样生长因子结合蛋白(IGFBP)-2在乳腺癌细胞DNA修复及化疗耐药中的作用
Cancers (Basel). 2024 May 31;16(11):2113. doi: 10.3390/cancers16112113.
7
Polymorphisms of DNA Repair Genes in Thyroid Cancer.甲状腺癌中 DNA 修复基因的多态性。
Int J Mol Sci. 2024 May 30;25(11):5995. doi: 10.3390/ijms25115995.
8
Homologous Recombination Repair Gene Mutations in Prostate Cancer: Prevalence and Clinical Value.前列腺癌中同源重组修复基因的突变:流行率和临床价值。
Adv Ther. 2024 Jun;41(6):2196-2216. doi: 10.1007/s12325-024-02844-7. Epub 2024 May 20.
9
Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer.靶向 MALAT1 通过破坏前列腺癌细胞中的同源重组增强对 PARP 抑制的敏感性。
Cancer Res Commun. 2023 Oct 9;3(10):2044-2061. doi: 10.1158/2767-9764.CRC-23-0089.
10
Efficacy and safety of veliparib plus chemotherapy for the treatment of lung cancer: A systematic review of clinical trials.维利帕里布联合化疗治疗肺癌的疗效和安全性:临床试验的系统评价。
PLoS One. 2023 Sep 8;18(9):e0291044. doi: 10.1371/journal.pone.0291044. eCollection 2023.
利用全基因组测序技术对 2658 个人类癌症中的染色体重排进行全面分析。
Nat Genet. 2020 Mar;52(3):331-341. doi: 10.1038/s41588-019-0576-7. Epub 2020 Feb 5.
4
Targeted drugs ramp up cancer mutability.靶向药物会加剧癌症的变异性。
Science. 2019 Dec 20;366(6472):1452-1453. doi: 10.1126/science.aaz9900.
5
A view on drug resistance in cancer.癌症耐药性的观点。
Nature. 2019 Nov;575(7782):299-309. doi: 10.1038/s41586-019-1730-1. Epub 2019 Nov 13.
6
Adaptive mutability of colorectal cancers in response to targeted therapies.结直肠癌对靶向治疗的适应性突变。
Science. 2019 Dec 20;366(6472):1473-1480. doi: 10.1126/science.aav4474. Epub 2019 Nov 7.
7
DNA double-strand break repair-pathway choice in somatic mammalian cells.体细胞核哺乳动物细胞中 DNA 双链断裂修复途径的选择。
Nat Rev Mol Cell Biol. 2019 Nov;20(11):698-714. doi: 10.1038/s41580-019-0152-0. Epub 2019 Jul 1.
8
Inadequate DNA Damage Repair Promotes Mammary Transdifferentiation, Leading to BRCA1 Breast Cancer.DNA 损伤修复不足促进乳腺转分化,导致 BRCA1 型乳腺癌。
Cell. 2019 Jun 27;178(1):135-151.e19. doi: 10.1016/j.cell.2019.06.002.
9
Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance.基因:在基因组稳定性、癌症干性及治疗抗性中的作用
J Cancer. 2019 May 14;10(9):2109-2127. doi: 10.7150/jca.30410. eCollection 2019.
10
Evidence that DNA repair genes, a family of tumor suppressor genes, are associated with evolution rate and size of genomes.有证据表明,DNA 修复基因是一类肿瘤抑制基因,与进化速率和基因组大小有关。
Hum Genomics. 2019 Jun 7;13(1):26. doi: 10.1186/s40246-019-0210-x.